Date: 2017-01-18
Type of information: Company acquisition
Acquired company: Disposable-Lab (France)
Acquiring company: Amatsigroup (France)
Amount:
Terms:
Details: Disposable-Lab is a French company providing innovative single use technology solutions for aseptic formulation & manufacturing needs for (bio) pharmaceutical customers. Founded in 2008 in Martillac (near Bordeaux | FR), Disposable-Lab benefited from a growing market demand on single use solutions for aseptic production of technical and clinical batches. Those single use isolators and disposable equipment package support the development of targeted new therapies based on biological molecules (immunotherapy in oncology, vaccines, etc...) as well as non-conventional processes (sterile powder filling, gene therapy, active vaccines and very small batch sizes…). Disposable-Lab is the first pharmaceutical facility specifically designed and built for “single use” processes in aseptic conditions from formulation to manufacturing of technical and clinical batches. With its Pyrofree® technology, the company is able to provide a wide range of apyrogenic sterile vials, ready to use and suitable for advanced technology in manufacturing processes for sterile drugs. Thanks to this acquisition, Amatsigroup will strengthen its leadership position within the manufacturing area for parenteral and sterile clinical batches and confirm its objective to exceed the €50 million revenue bar by 2017 (vs €44 million prior year).
Related:
